Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment (Q66396638)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment |
clinical trial |
Statements
A Phase I, Open Label, Multicenter, Single Dose Study to Evaluate the Pharmacokinetics of Dabrafenib in Healthy Subjects With Normal Renal Function and Subjects With Impaired Renal Function (English)
0 references
19 December 2016
0 references
2 October 2019
0 references
32
0 references
18 year
0 references
75 year
0 references